EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: November 2018

IGEM Therapeutics Announces Final Close of £5 million Series A Financing Round

November 30, 2018

New investors Alsa Holdings and UCL Technology Fund join Epidarex Capital Proceeds will allow IGEM to continue development of IgE therapeutic antibody portfolio and novel

Read »

Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer

November 8, 2018

Seasoned CEO with 30 years’ experience in the healthcare industry Edinburgh, United Kingdom, 8 November 2018 – Edinburgh Molecular Imaging (EM Imaging), the optical molecular

Read »

EPIDAREX CAPITAL – CATALYZING INNOVATION IN HEALTH SCIENCE AND TECHNOLOGY

Month: November 2018

IGEM Therapeutics Announces Final Close of £5 million Series A Financing Round

Edinburgh Molecular Imaging Appoints Bernhard Sixt as New Chief Executive Officer

Categories

Archives